Shandong Buchang Pharmaceuticals Co., Ltd.

Shandong Buchang Pharmaceuticals Co., Ltd. saw a daily gain, reaching an intraday high, contrasting with the modest rise of the China Shanghai Composite. Despite this, the company has faced a slight weekly decline and significant year-to-date and annual decreases, alongside challenges in long-term growth and declining net sales.

Shandong Buchang Pharmaceuticals Co., Ltd. saw a significant stock decline today, contrasting with a modest gain in the China Shanghai Composite. Over the past year, the company has underperformed the market, with declining net sales and operating profit, while maintaining a market capitalization of CNY 16,358 million.

Shandong Buchang Pharmaceuticals Co., Ltd. saw a notable increase in its stock today, contrasting with the broader market's modest gains. However, the company has struggled over the past year, with declining net sales and operating profit, while maintaining a market capitalization of CNY 16,358 million and a dividend yield of 2.64%.

Shandong Buchang Pharmaceuticals Co., Ltd. faced a notable stock decline, reaching an intraday low and experiencing a weekly decrease. The company reported a modest annual return, significantly lagging behind the broader market. Long-term metrics reveal declining net sales and operating profit, alongside ongoing financial pressures reflected in its return on equity.

Shandong Buchang Pharmaceuticals Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Over the past week and month, the stock has also decreased, while annual returns remain lower than the China Shanghai Composite. The company faces challenges despite strong cash flow and a high dividend yield.